中东呼吸综合征冠状病毒及其疫苗和特异性药物的研发

瞿涤,陆路,姜世勃

微生物与感染 ›› 2015, Vol. 10 ›› Issue (4) : 200-207.

PDF(1684 KB)
欢迎访问《微生物与感染》官方网站,今天是
PDF(1684 KB)
微生物与感染 ›› 2015, Vol. 10 ›› Issue (4) : 200-207.
特约专稿

中东呼吸综合征冠状病毒及其疫苗和特异性药物的研发

  • 瞿涤,陆路,姜世勃
作者信息 +

Middle East respiratory syndrome coronavirus and development of vaccines and specific drugs for its control

  • QU Di, LU Lu, JIANG Shi­Bo
Author information +
文章历史 +

摘要

中东呼吸综合征冠状病毒(MERS­-CoV)是引起MERS的病原。本文就MERS­-CoV的分类、特性、决定宿主特异性的分子结构及其疫苗研究状况和特异性药物研究进展等方面进行综述。

Abstract

Middle East respiratory syndrome (MERS) is a viral infection caused by a novel coronavirus (MERS­-CoV). In this review, we focus on the classification, molecular structure and the proteins related to tissue tropisms and host range of MERS­-CoV. The efforts on development of drugs and vaccines for the control of MERS­-CoV are also discussed.

关键词

中东呼吸综合征冠状病毒 / 中东呼吸综合征 / 疫苗 / 抗中东呼吸综合征冠状病毒中和抗体

Key words

Middle East respiratory syndrome coronavirus / Middle East respiratory syndrome / Vaccine / Anti­-Middle East respiratory syndrome coronavirus neutralization antibody

引用本文

导出引用
瞿涤,陆路,姜世勃. 中东呼吸综合征冠状病毒及其疫苗和特异性药物的研发[J]. 微生物与感染. 2015, 10(4): 200-207
QU Di, LU Lu, JIANG Shi-Bo. Middle East respiratory syndrome coronavirus and development of vaccines and specific drugs for its control[J]. Journal of Microbes and Infections. 2015, 10(4): 200-207

基金

国家自然科学基金(81173098)


PDF(1684 KB)

Accesses

Citation

Detail

段落导航
相关文章

/